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Background: Despite advances in the treatment of childhood cancer, some children continue to die from their disease. This study
aimed to assess the impact of specialist paediatric palliative care services (SPPCSs) on the number of hospital admissions in
children who subsequently died from cancer in Yorkshire, UK.
Methods: An extract of patients aged 0–19 years from the Yorkshire Specialist Register of Cancer in Children and Young People
(YSRCCYP) diagnosed from 1990 to 2009 were linked to inpatient hospital episodes data and a SPPCS database. Deaths were
included if they occurred before 31 August 2011. Differences in hospital admission patterns were assessed using negative
binomial regression and presented as incidence rate ratios (IRRs).
Results: Of 2508 children on the YSRCCYP, 657 (26%) had died by the censoring date. A total of 211 children had been referred to
the local SPPCS, of whom 182 (86%) had subsequently died. Referral to SPPCS was associated with a significant reduction in the
rate of planned hospital admissions (IRR¼ 0.60, 95% CI 0.43–0.85). Central nervous system tumours showed significant decreases
for all planned and emergency admissions compared with all other diagnostic groups.
Conclusion: Referral to SPPCS significantly reduced the number of planned hospital admissions for children and young people
with cancer before their death, which are often integral to paediatric oncology treatment regimens. Overall, our findings show that
SPPCS have a role in reducing hospital admissions during end of life care of paediatric cancer patients with potential personal,
social and economic benefits.
Specialist Paediatric Palliative Care Services (SPPCSs) have been
developed rapidly over the last three decades, but as a medical
subspecialty are still in their infancy. Despite advances in the
treatment of childhood cancer, some children continue to die from
their disease, with cancer being the second most common cause of
death in children and young people aged 0–19 years of age (Office
for National Statistics, 2005). SPPCSs are therefore an important
component of children’s oncology services, and ensuring that
equitable access to palliative care services is one of the aims set out
in the Improving Outcomes Guidance published in 2005 (National
Institute for Health and Clinical Excellence, 2005), and were
highlighted again by the Department of Health as an important
component of the Oncology and Malignant Haematology specia-
lised paediatric services in 2008 (Department of Health, 2008b). In
the United Kingdom, approximately a third of children and young
people who die from cancer have been referred to SPPCS before
death and this proportion has not changed since 1990 (Fraser et al,
2011b). Referral to SPPCS for children with life-limiting conditions
has resulted in more children dying in the community (home or
hospice) than hospital (Fraser et al, 2011a). SPPCS vary across the
world, for example, services were available in 58% of Children’s
Oncology Group institutions, the majority of which are in North
America, but were only used by a small minority of patients
(Johnston et al, 2008), and in Taiwan, only 7.2% of children who
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subsequently died from cancer had been cared for by a hospice
(Tang et al, 2011). In two states in the United States, a survey of
paediatricians found that 74% of them were reluctant to refer
patients to SPPCS, with the main reasons being related to family
reluctance to accept palliative care, families viewing palliative care
as giving up and difficulty in determining the right time to refer to
palliative care (Knapp and Thompson, 2012).
Children with cancer who are dying are frequently admitted to
hospital which can be disrupting and distressing for the child and
their family. A reduction in these events would potentially have
clinical, social and economic benefits, but, currently, no data are
available on the pattern or numbers of hospital admissions that
occur during end of life care, and no literature has been published
on whether the involvement of SPPCS might reduce hospital
inpatient admissions and benefit this group. Yorkshire, UK, has a
unique combination of overlapping data sets on childhood cancers,
hospital admissions and children accessing SPPCS that has allowed
us to measure the impact of SPPCS on the number of hospital
admissions in children before their death from cancer.
MATERIALS AND METHODS
The cohort for this study was extracted from the Yorkshire
Specialist Register of Cancer in Children and Young People
(YSRCCYP) and includes patients aged 0–19 years diagnosed from
1990 to 2009. Only individuals resident in the former Yorkshire
Regional Health Authority (Yorkshire) were included to have
comparative ‘catchment’ areas to the SPPCS.
The YSRCCYP contains clinical and demographic information on
all children and young people diagnosed with cancer in Yorkshire.
Data used in these analyses included age at diagnosis, gender, date of
death, deprivation category, year of diagnosis and International
Classification of Childhood Cancer (ICCC) diagnostic groups
(Steliarova-Foucher et al, 2005). Date of death recorded on the
YSRCCYP is obtained through automated death notifications from the
Office for National Statistics death registration records. Deprivation
category was determined using the Townsend deprivation score,
which is based on unemployment, non-car ownership, non-home
ownership and household overcrowding (Phillimore et al, 1994).
Townsend deprivation scores were derived by English census output
area of residence at time of diagnosis using 2001 census data, and were
split into five categories from least deprived to most deprived. The
ICCC groups were aggregated for certain analyses to avoid small
numbers into: leukaemia (I), lymphoma (II), central nervous system
(CNS) tumours (III) and other solid tumours (IV–XII). Ethnic group
was assigned from the linked data (see below).
Linked data. The SPPCS in the former Yorkshire Regional Health
Authority is provided by Martin House Childrens’ Hospice (2012).
Martin House Children’s Hospice has been caring for children and
young adults (aged up to 35 years) with life-limiting conditions
since 1987. In this SPPCS, medical support was slowly increased
from part to full time in house cover (between 1987 and 2004), and
a full time consultant in Paediatric Palliative Medicine was
appointed from 2004 onwards.
Using data collected by the SPPCS, any individual who had been
accepted for care by the SPPCS was flagged on the YSRCCYP.
In addition to this, inpatient hospital episode statistics (HES)
data were linked to the YSRCCYP. HES data contains all
admissions to National Health Service hospitals in England
(NHS Information Centre, 2011), and although this data has been
recorded for inpatient admissions since 1989, it was not deemed to
be complete enough for research purposes until 1996. Thus, all
individuals registered on the YSRCCYP who were alive from
1 January 1996 onwards were linked to inpatient HES data.
Data manipulation. The HES data provide details on individual
‘finished consultant episodes’ (FCEs). An FCE is not the same as a
hospital admission; one hospital admission can comprise one or
more FCEs if a patient is cared for by more than one consultant
during their admission (NHS Information Centre, 2011). There-
fore, continuous inpatient spells (CIPSs) were constructed for each
patient, each CIPS representing each unique admission for every
patient. A detailed description of the algorithm used to create the
CIPS is given in the user guide by the National Centre for Health
Outcomes Development (2009).
Planned hospital admissions are the basis of treatment for most
paediatric cancer patients, so in order to assess the potential impact
of palliative care involvement, each hospital admission was
classified as planned (elective) or emergency (all other admission
codes,497% were emergency admissions in this cohort) using the
admission method codes recorded in the first FCE in each CIPS.
A ‘proxy date of referral’ for patients who had died and were not
referred for SPPCS was estimated by simulating the time from
diagnosis to referral from a negative binomial distribution based on
those patients who were referred to SPPCS (Figure 1). The
simulation was performed by ICCC group, and summaries of the
referral time periods are given in Table 1. This allowed the number
Time from diagnosis to referral
Date of referral to palliative care
Patients referred to Specialist Palliative Care Service
Patients not referred to Specialist Palliative Care Service
Date of diagnosis Date of death
Proxy date of referral to palliative careDate of diagnosis Date of death
Figure 1. Calculation of time to referral.
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of hospital admissions (total, planned and emergency) for this time
period to be calculated for each individual. This method was
preferred to simply analysing the rate of admissions in a predefined
period (for example, 3 or 6 months before death) as the disease
trajectories varied widely between the ICCC groups.
Assignment of ethnic category was achieved using ethnicity as
recorded within HES data. Ethnicity within HES should be
self-reported by the patient. Individuals with multiple ethnicity
codes were assigned their most commonly reported ethnicity group
unless the most common ethnicity was ‘not known’ (NCIN, 2009).
The 16 census ethnic groups (Census, 2001) were merged into four
combined groups to avoid very small numbers in some categories:
White (White: British; White: Irish; White: Other White), South
Asian (Asian or Asian British: Indian; Asian or Asian British:
Pakistani; Asian or Asian British: Bangladeshi; Asian or Asian
British: Other Asian), Black (Black or Black British: Black
Caribbean; Black or Black British; Black African; Black or Black
British: Other Black) and other ethnic groups (Mixed: White and
Black Caribbean; Mixed: White and Black African; Mixed: White
and Asian; Mixed: other mixed, chinese and other ethnic group).
Statistical analyses. The clinical and demographic variables were
described for the whole cohort and subdivided into those who had
died without referral to SPPCS and those who had been referred
for SPPCS. As no previous literature exists on hospital admissions
occurring during end of life care for childhood cancer, the variables
included within the analysis as mentioned previously were chosen
based on standard variables used within the literature of survival of
childhood cancer (Wilkinson et al, 2001; Magnani et al, 2006; Basta
et al, 2011; van Laar et al, 2012). The impact of referral on SPPCS
was explored using negative binomial regression modelling (which
was chosen over Poisson regression due to overdispersion), with
the total number of hospital admissions as the main outcome. We
modelled hospital admission rates by including each person’s post-
referral follow-up time in the model as an exposure term. Two
further negative binomial regression models were run with number
of planned hospital admissions and the total number of emergency
hospital admissions during the same time period.
Ethics. The YSRCCYP is a member of the UK Association of
Cancer Registries, which currently holds section 251 permission
from the National Information Governance Board to hold and
process data on children and young people with cancer without
obtaining consent. Ethical approval for this study was obtained
from the Bradford NHS Ethics Committee (09/H1302/81).
RESULTS
There were 2508 individual patients diagnosed between 1990 and
2009, aged 0–19 years and registered on the YSRCCYP (Table 2).
Of these, 26.2% (n¼ 657) had died before the extract date (31
August 2011). In total, 211 children had been referred to SPPCS, of
which 182 had died before the extract date (Figure 2). Therefore,
27.7% of those who had died were referred to SPPCS before death.
The groups (those who died and had been referred (n¼ 182)
compared with those who died and were not referred to SPPCS
(n¼ 475)) did not differ significantly in terms of gender,
deprivation category, ethnicity or year group of diagnosis. The
age groups did differ significantly with a smaller percentage in the
oldest age group referred to SPPCS. The groups also differed in
terms of ICCC diagnostic category with CNS tumours forming the
largest subgroup in those referred to SPPCS (Table 2).
The linkage rate to the HES data set was 89.1% in this cohort.
Those who did not link tended to be male, were diagnosed under
the age of 5 and were diagnosed towards the beginning of the study
period. This linkage rate did not differ significantly between the
SPPCS group and the remainder of the cohort (Table 3). The mean
number of total hospital admissions between referral and death
was higher in the group not referred to SPPCS (14.1 vs 4.7, t¼ 4.11,
Po0.001) as were the number of planned hospital admissions
between referral and death (10.0 vs 2.6, t¼ 4.01, Po0.001), and the
mean number of emergency admissions during this time period
(4.1 vs 2.1, t¼ 2.97, P¼ 0.003).
The results from the adjusted negative binomial model (Table 4)
showed that patients referred to SPPCS had significantly lower
planned admission rates compared with those who were not
referred (incidence rate ratio (IRR)¼ 0.60, 95% CI 0.43–0.85),
however, there was no significant effect of referral on overall
admission rates or emergency admission rates. Children diagnosed
at an older age had significantly fewer hospital admission rates by
3% (IRR¼ 0.97, 95% CI 0.95–1.00) for total admissions. This effect
was also seen in planned hospital admissions, but not for
emergency hospital admissions. Children with CNS tumours had
significantly fewer total hospital admissions compared with those
with leukaemia (IRR¼ 0.41, 95% CI 0.28–0.61), which was
consistent in both emergency and planned hospital admissions.
In addition, the models show a significant increase in total
emergency and planned hospital admissions for every year increase
over the study period, 1990–2009 (total admissions IRR¼ 1.09,
95% CI 1.06–1.12).
DISCUSSION
This novel study has shown that although less than a third of
children and young people who died of their cancer were referred
to a SPPCS, a referral was significantly associated with fewer
planned hospital inpatient admissions, by 40% on average. This is a
particularly significant finding in the general context of increasing
hospitalisation rates for survivors of childhood and adolescent
cancer and was seen consistently across all four major diagnostic
groups. An explanation for the relatively small proportion of
people referred to SPCCS is unclear; possible reasons might include
family reluctance to accept palliative care and a lack of education
about SPCCS (Knapp and Thompson, 2012), or ease of access
and proximity to Martin House. Hospital admissions are
Table 1. Time from diagnosis to referral to specialist palliative care
service by ICCC classification
ICCC
classification
Number of
Patients
Median time to
referral (days)
IQR
Leukaemia 32 518 363 995
Lymphoma 14 368 189 595
CNS 84 262 110 1206
Neuroblastoma 19 319 157 647
Retinoblastoma 0 — — —
Renal 6 390 78 1205
Hepatic 3 122 49 339
Bone 18 561 206 678
Soft tissue 29 273 194 562
Germ cell 2 169 125 212
Other epitheliala 3 582 109 824
Other 0 — — —
Abbreviations: CNS¼ central nervous system; ICCC¼ International Classification of Child-
hood Cancer; IQR¼ inter quartile range.
aClassification includes: adrenocortical carcinomas, thyroid carcinomas, nasopharyngeal
carcinomas, malignant melanomas and other unspecified carcinomas.
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considered socially disruptive and financially draining for children
and families, and more hospital admissions have been associated
with distress in fathers of childhood cancer patients (Sloper, 2000)
and a higher risk of poor adjustment in siblings (Sloper and While,
1996). Delivery of appropriate end of life care that reduces the
frequency of these events would be beneficial to patients and their
families, as well as the NHS. Martin House offer a range of services
that could help reduce hospital admissions, including a 24-h
on-call medical service, with the ability for home visits as well as
the ability to manage symptoms as inpatients when needed.
The World Health Organisation definition of paediatric
palliative care states that ‘It begins when illness is diagnosed, and
continues regardless of whether or not a child receives treatment
directed at the disease.’ However, the adult palliative care model,
Table 2. Clinical and demographic information
Yorkshire specialist register of cancer in
children and young people
Martin house childrens’ hospice
Total col % Died col % Total col % Died col %
Total 2508 100 657 100 211 100 182 100
Gender
Male 1551 61.8 481 73.2 153 72.5 132 72.5
Female 957 38.2 176 26.8 58 27.5 50 27.5
Age group at diagnosis
0–4 years 932 37.2 253 38.5 91 43.1 73 40.1
5–9 years 510 20.3 125 19.0 57 27.0 50 27.5
10–14 years 533 21.2 147 22.4 49 23.2 45 24.7
15–19 years 533 21.2 132 20.1 14 6.6 14 7.7
Ethnic category
White 1676 66.8 328 49.9 125 59.2 100 54.9
Mixed 12 0.5 3 0.5 2 0.9 2 1.1
South Asian 176 7.0 42 6.4 6 2.8 6 3.3
Black 16 0.6 3 0.5 2 0.9 1 0.5
Other 31 1.2 11 1.7 7 3.3 6 3.3
Not knowna 597 23.8 270 41.1 69 32.7 67 36.8
Deprivation category
1 (least deprived) 480 19.1 134 20.4 34 16.1 28 15.4
2 514 20.5 120 18.3 41 19.4 36 19.8
3 443 17.7 106 16.1 41 19.4 36 19.8
4 407 16.2 112 17.1 41 19.4 34 18.7
5 (most deprived) 663 26.4 185 28.2 54 25.6 48 26.4
Not Known 1 0.0 0 0 0 0 0 0
ICCC diagnostic category
Leukaemia 703 28.0 170 25.9 33 15.6 24 13.2
Lymphoma 369 14.7 61 9.3 14 6.6 13 7.1
CNS 508 20.3 164 25.0 84 39.8 72 39.6
Neuroblastoma 145 5.8 66 10.0 19 9.0 18 9.9
Retinoblastoma 58 2.3 1 0.2 0 0 0 0
Renal 119 4.7 19 2.9 6 2.8 4 2.2
Hepatic 23 0.9 8 1.2 3 1.4 3 1.6
Bone 128 5.1 57 8.7 18 8.5 18 9.9
Soft tissue 209 8.3 82 31.8 29 13.7 26 0.5
Germ Cell 178 7.1 15 2.3 2 0.9 1 0.5
Other epithelial 64 2.6 12 1.8 3 1.4 3 1.6
Other 4 0.2 2 0.3 0 0 0 0
Year diagnosis
1990–1994 618 24.6 219 33.3 63 29.9 57 31.3
1995–1999 595 23.7 186 28.3 60 28.4 53 29.1
2000–2004 667 26.6 144 21.9 54 25.6 44 24.2
2005–2009 628 25.0 108 16.4 34 16.1 28 15.4
Abbreviations: col¼ column; CNS¼ central nervous system; ICCC¼ International Classification of Childhood Cancer.
aEthnic category was obtained from HES so only available for those alive in 1996 and successfully linked to HES.
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whereby palliative care is a phase that starts after disease-directed
treatment has failed, tends to be followed in paediatric oncology
patients. This may explain why the groups of patients who were
not referred for SPPCS had significantly higher planned hospital
admission rates than the SPPCS group, that is, they may still be
receiving tumour-directed treatment, which could mean they are
more likely to be admitted for side effects from treatment.
A previous UK publication (Shah et al, 2011), which looked at the
number of hospital episodes by place of death in children who died
from cancer, showed those patients who died at home or in a
hospice spent fewer days in hospital in the last 6 months of life
than those who had died in hospital. Our results are consistent
with these observations, but this was a descriptive analysis, and
involvement of SPPCS was not known in these patients. The place
of death was not available for the patients in the current study.
Children with CNS tumours had a significantly lower rate of
admissions to hospital (whether planned or emergency) compared
with leukaemia (by 60% on average). There are several reasons that
may explain this finding. Inpatient treatment of CNS tumours is
less likely than for leukaemia because the mainstay of leukaemia
treatment is chemotherapy and as such there is a higher incidence
of immunosupression and therefore an increased risk of febrile
neutropenia. Side effects from CNS tumours, such as vomiting or
swelling, around the tumour in response to steroids can be
managed at home, making inpatient treatments less likely for this
group. CNS tumours are a heterogeneous group of tumours,
including a spectrum of both low and high grade tumours,
compared with a homogenous group of leukaemia patients who are
treated on inpatient-intensive treatment protocols.
The trend in children diagnosed more recently having higher
rates of hospital admissions may represent changes in practice,
such as increased levels of therapy and the use of aggressive relapse
treatments. Although this study was not designed to assess
the health economics of hospital admissions vs SPPCS care, the
reduction in hospitalisation rates for planned admissions
associated with referral to SPPCS helps to ameliorate the impact
of increasing admissions rates over time, and such reductions
clearly would be financially beneficial to the NHS.
The Department of Health Children and Young People’s Health
Outcomes Forum has called for improved quality and availability
of data on children with disability, life-limiting conditions and
complex needs in which children with cancer are included (Lewis
and Lenehan, 2012). This study provides valuable evidence for the
benefit of the involvement of SPPCS in the care of the child dying
from cancer. This information will also be useful for the
Department of Health in England’s Palliative Care Funding Review
(Hughes-Hallet et al, 2011) and local commissioners (Craft and
Killen, 2008; Department of Health, 2008a).
Strengths of this study include its population base, size and
quality utilising 20 years of routinely collected data, but it is not
without its limitations. Missing ethnicity data hampered any
meaningful assessment of inequalities in relation to outcomes or
service access by the ethnic group, and the availability of the HES
data was restricted to the period from 1996 onwards.
The study relied on successful linkage of the HES and
YSRCCYP data, as well as successfully flagging up of those
referred to SPCCS on the YSRCCYP. Although both these methods
were carried out using detailed linking approaches, typographical
errors for some of the data could have led us to miss some patients.
Although the linkage rate of HES to the YSRCCYP was high
(89.1%), there were some differences between those cases that
SPPCS data
YSRCCYP
Died
n =657
Data sources Number ofpatients
Total
number of
patients
registered
n =2508
ONS death
certificate
data
Eligible for
HES linkage
Successful
HES linkage
n =311
88.9%
n =132
89.8%
Died
after
1/1/1996
n =147
Referred 
to SPPCS#
n =182
Not
referred
to SPPCS
n =475
# Note 211 registered patients referred to SPPCS but 29 patients still alive at
time of analysis
Died
after
1/1/1996
n =350
Figure 2. Data sources.
Table 3. Summary of hospital admissions by referral status
YSRCCYP
Not
referred to
SPPCS
Referred to
SPPCS
Total deaths 657 475 182
Eligible for HES linkage 497 350 147
Successful linkage to HES 443 (89.1%) 311 (88.9%) 132 (89.8%)
Mean (s.d.) Mean (s.d.) Mean (s.d.)
Total number of hospital
admissions between referral to
SPPCS and deatha
11.3 (22.7) 14.1 (25.8) 4.7 (10.3)
Number of planned hospital
admissions between referral to
SPPCS and deatha
7.8 (18.0) 10.0 (20.7) 2.6 (6.0)
Number of emergency hospital
admissions between referral to
SPPCS and deathb
3.5 (6.1) 4.1 (6.3) 2.1 (5.2)
Abbreviations: HES¼ hospital episode statistics; SPPCS¼ Specialist Paediatric Palliative
Care Service; YSRCCYP¼Yorkshire Specialist Register of Cancer in Children and Young
People.
aPo0.0001 t-test.
bP¼ 0.003 t-test.
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linked and those that did not. Cases less likely to link tended to be
diagnosed towards the beginning of the study period, be under the
age of 5 and be male. As the cohort of those referred to SPCCS was
small, data were carefully interrogated to ensure matches were not
missed based on simple typographical errors.
In order to compare the rate of admissions between those who
were and were not referred to SPCCS, we used a proxy date for
referral in patients who were not referred to SPCCS. A simulation
approach to estimate the date of referral was adopted in an attempt
to minimise any biases, as would be caused by simply using an
average value, such as the mean or median. This approach was
preferred to the option of looking at admissions in a specific time
period towards the end of life (i.e., 6 months), because of the
variations in disease trajectories between diagnostic groups.
We investigated inpatient hospital admissions but additional
sources of hospital contact include outpatient visits and accident
and emergency (A&E) department attendances. This data have
been collected more recently by the NHS, and future work should
include an assessment of A&E usage among these patients.
CONCLUSIONS
Although less than a third of children and young people who
subsequently died of cancer were referred to a SPPCS before death,
referral was significantly associated with lower rates of planned
hospital admissions in this cohort of children. The SPPCS clearly
have a role in reducing hospital admissions during end of life care
of paediatric cancer patients with potential personal, social and
economic benefits.
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